NIH-funded research R21 grant

Investigating the role of Bcl-2 in vision loss from age-related macular degeneration

Official title: Bcl-2, Subretinal Scar Formation and Neovascular AMD

Funded at University of Wisconsin-Madison · NIH-10733960 · Data updated 2026-11-12

This study is looking at how inflammation affects vision loss in older adults with age-related macular degeneration (AMD) and is exploring a protein called Bcl-2 to see if it plays a role in healing and could help find new treatments.

More Scar research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2025
Funding year2023
Award (this year)$427,625
NIH project number1R21EY034646-01A1
Project IDNIH-10733960 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults, particularly those diagnosed with neovascular age-related macular degeneration.

Less likely to help

Patients with early-stage AMD or those without any signs of neovascularization may not benefit from this research.

What this research studies

This research focuses on age-related macular degeneration (AMD), a condition that typically affects individuals over 60 and leads to vision loss. It aims to understand how inflammation contributes to the formation of subretinal scars and choroidal neovascularization (CNV) in neovascular AMD. The study will explore the role of Bcl-2, a protein that may prolong inflammation and affect the healing process in the eye. By examining how Bcl-2 influences mononuclear phagocytes and their role in these processes, the research seeks to uncover new insights into AMD progression and potential treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients with age-related macular degeneration, potentially preserving vision and enhancing quality of life.

How similar studies have gone: Previous research has shown promising results in understanding the role of inflammation in AMD, but this specific approach focusing on Bcl-2 is relatively novel.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Sorenson, Christine M — University of Wisconsin-Madison
  • Study coordinator: Sorenson, Christine M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.